These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19242790)

  • 1. Test of Hardy-Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions.
    Yu KD; Di GH; Fan L; Shao ZM
    Breast Cancer Res Treat; 2009 Oct; 117(3):675-7. PubMed ID: 19242790
    [No Abstract]   [Full Text] [Related]  

  • 2. SNP selection and multidimensional scaling to quantify population structure.
    Miclaus K; Wolfinger R; Czika W
    Genet Epidemiol; 2009 Sep; 33(6):488-96. PubMed ID: 19194989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact and quantification of the sources of error in DNA pooling designs.
    Jawaid A; Sham P
    Ann Hum Genet; 2009 Jan; 73(1):118-24. PubMed ID: 18945289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel generating protective single nucleotide polymorphism barcode for breast cancer using particle swarm optimization.
    Yang CH; Chang HW; Cheng YH; Chuang LY
    Cancer Epidemiol; 2009 Aug; 33(2):147-54. PubMed ID: 19679063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hardy-Weinberg equilibrium in genetic epidemiology].
    Liu H; Hu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 35(1):90-3. PubMed ID: 20130370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing Hardy-Weinberg equilibrium using mother-child case-control samples.
    Chen J; Zheng H; Wilson ML; Kraft P
    Genet Epidemiol; 2009 Sep; 33(6):539-48. PubMed ID: 19194980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validating the meta-analytical results on MDM2, CASP8, XRCC3 polymorphisms and breast cancer risk: examination of Hardy-Weinberg Equilibrium.
    Sergentanis TN; Economopoulos KP
    Breast Cancer Res Treat; 2011 Apr; 126(3):819-23. PubMed ID: 21161371
    [No Abstract]   [Full Text] [Related]  

  • 8. Genome-wide association studies provoke debate and a new look at strategy.
    Tuma RS
    J Natl Cancer Inst; 2009 Aug; 101(15):1041-3. PubMed ID: 19638504
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality control for genome-wide association studies.
    Weale ME
    Methods Mol Biol; 2010; 628():341-72. PubMed ID: 20238091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using both cases and controls for testing hardy-weinberg proportions in a genetic association study.
    Wang J; Shete S
    Hum Hered; 2010; 69(3):212-8. PubMed ID: 20203526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women.
    Romanowicz-Makowska H; Smolarz B; Makowski M; Połać I; Pertyński T
    Pol J Pathol; 2008; 59(4):201-4. PubMed ID: 19391486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inspection of a deviation from Hardy-Weinberg equilibrium in familial breast cancer cases from a case-control study in a meta-analysis.
    Yu KD; Shao ZM
    Breast Cancer Res Treat; 2011 Jun; 127(2):577-9. PubMed ID: 21279435
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease.
    Araújo AP; Ribeiro R; Pinto D; Pereira D; Sousa B; Mauricio J; Lopes C; Medeiros R
    DNA Cell Biol; 2009 May; 28(5):265-9. PubMed ID: 19388850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An easy-to-implement approach for analyzing case-control and case-only studies assuming gene-environment independence and Hardy-Weinberg equilibrium.
    Lee WC; Wang LY; Cheng KF
    Stat Med; 2010 Oct; 29(24):2557-67. PubMed ID: 20799260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma genetics and genomics 2009.
    Weiss ST; Raby BA; Rogers A
    Curr Opin Genet Dev; 2009 Jun; 19(3):279-82. PubMed ID: 19481925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan.
    Wang HC; Chiu CF; Tsai RY; Kuo YS; Chen HS; Wang RF; Tsai CW; Chang CH; Lin CC; Bau DT
    Anticancer Res; 2009 Oct; 29(10):3897-901. PubMed ID: 19846925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer.
    Varadi V; Brendle A; Grzybowska E; Johansson R; Enquist K; Butkiewicz D; Pamula-Pilat J; Pekala W; Hemminki K; Lenner P; Försti A
    Cancer Genet Cytogenet; 2009 Apr; 190(2):71-4. PubMed ID: 19380022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of homocysteine levels in colorectal and breast cancer patients.
    Ferroni P; Palmirotta R; Martini F; Riondino S; Savonarola A; Spila A; Ciatti F; Sini V; Mariotti S; Del Monte G; Roselli M; Guadagni F
    Anticancer Res; 2009 Oct; 29(10):4131-8. PubMed ID: 19846961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Some suggestions on the realization of cancer genome-wide association studies in China].
    Fang FD
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):719-20. PubMed ID: 20021874
    [No Abstract]   [Full Text] [Related]  

  • 20. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
    Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.